Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Urinalysis Market by Product (Instruments, Consumables) , by Application (Disease Screening, Pregnancy & Fertility Testing) by End User (Hospitals, Clinical Laboratories, Home Care) : Global Opportunity Analysis and Industry Forecast, 2024-2033

A00901

Pages: 280

Charts: 57

Tables: 134

Urinalysis Market Research, 2033

The global urinalysis market size was valued at $3.1 billion in 2023, and is projected to reach $6.8 billion by 2033, growing at a CAGR of 8.3% from 2024 to 2033. The urinalysis market is primarily driven by the rising prevalence of chronic diseases such as diabetes, kidney disorders, and urinary tract infections, which necessitate regular monitoring. The growing geriatric population, which is more susceptible to these conditions, further fuels market demand. Technological advancements in urinalysis devices, offering enhanced accuracy and ease of use, contribute significantly to market growth.

Market Introduction and Definition

Urinalysis is a diagnostic test used to evaluate various aspects of a person's urine, providing valuable insights into their overall health. Urinalysis is a non-invasive procedure which involves examining a urine sample for different components, including color, clarity, specific gravity, pH level, protein, glucose, ketones, bilirubin, urobilinogen, nitrites, and leukocytes. Each component can indicate different conditions or abnormalities within the body. For instance, the color and clarity of urine may suggest hydration levels or the presence of blood or other substances. Abnormal levels of protein, glucose, or ketones might signal kidney disease or diabetes. Additionally, the presence of nitrites and leukocytes can indicate a urinary tract infection. Urinalysis is often performed as part of routine health check-ups, to monitor certain medical conditions, or to aid in diagnosing urinary tract infections, kidney diseases, diabetes, or other systemic disorders. 

Key Takeaways 

  • The urinalysis market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major urinalysis industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
  • The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.

 Key Market Segments

  • By Product
    • Instruments
    • Consumables
  • By Application
    • Disease Screening
    • Pregnancy & Fertility Testing
  • By End User
    • Hospitals
    • Clinical Laboratories
    • Home Care
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA

 
Key Market Players

  • Abbott Laboratories
  • Siemens Healthcare GmbH
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • Thermo Fisher Scientific Inc. 
  • Sysmex Corporation
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc. 
  • Quidel Corporation
  • ACON Laboratories, Inc.
  • Arkray Inc

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: URINALYSIS MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Instruments

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Consumables

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: URINALYSIS MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Disease Screening

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Pregnancy And Fertility Testing

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: URINALYSIS MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Clinical Laboratories

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Home Care

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: URINALYSIS MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Urinalysis Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Urinalysis Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Urinalysis Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Urinalysis Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Urinalysis Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Urinalysis Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Urinalysis Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Urinalysis Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Urinalysis Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Urinalysis Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Urinalysis Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Urinalysis Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Urinalysis Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Urinalysis Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Urinalysis Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Urinalysis Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Urinalysis Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Urinalysis Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Urinalysis Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Urinalysis Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Urinalysis Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Urinalysis Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Urinalysis Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Urinalysis Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Urinalysis Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Abbott Laboratories

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Sysmex Corporation

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Siemens Healthcare GmbH

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. ACON Laboratories, Inc.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Arkray Inc

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. F. Hoffmann-La Roche Ltd.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Quidel Corporation

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Thermo Fisher Scientific Inc. 

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Bio-Rad Laboratories, Inc. 

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL URINALYSIS MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL URINALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL URINALYSIS MARKET FOR CONSUMABLES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL URINALYSIS MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL URINALYSIS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL URINALYSIS MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL URINALYSIS MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL URINALYSIS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL URINALYSIS MARKET FOR HOME CARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL URINALYSIS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA URINALYSIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 16. U.S. URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 17. U.S. URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 18. U.S. URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 19. CANADA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 20. CANADA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 21. CANADA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 22. MEXICO URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE URINALYSIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. FRANCE URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 30. FRANCE URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. FRANCE URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 32. GERMANY URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 33. GERMANY URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. GERMANY URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. ITALY URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 36. ITALY URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. ITALY URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. SPAIN URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 39. SPAIN URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 40. SPAIN URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 41. UK URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 42. UK URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 43. UK URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. RUSSIA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 45. RUSSIA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. RUSSIA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. REST OF EUROPE URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 48. REST OF EUROPE URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 49. REST OF EUROPE URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. ASIA-PACIFIC URINALYSIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 51. ASIA-PACIFIC URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. CHINA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 55. CHINA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. CHINA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 57. JAPAN URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 58. JAPAN URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. JAPAN URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 60. INDIA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 61. INDIA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. INDIA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH KOREA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH KOREA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH KOREA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 66. AUSTRALIA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 67. AUSTRALIA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 68. AUSTRALIA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. THAILAND URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 70. THAILAND URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. THAILAND URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. MALAYSIA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 73. MALAYSIA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 74. MALAYSIA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 75. INDONESIA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 76. INDONESIA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 77. INDONESIA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 78. REST OF ASIA PACIFIC URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 81. LAMEA URINALYSIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 82. LAMEA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 83. LAMEA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 85. BRAZIL URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 86. BRAZIL URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 87. BRAZIL URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 88. SOUTH AFRICA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 89. SOUTH AFRICA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH AFRICA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 91. SAUDI ARABIA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 92. SAUDI ARABIA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 93. SAUDI ARABIA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 94. UAE URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 95. UAE URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 96. UAE URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 97. ARGENTINA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 98. ARGENTINA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 99. ARGENTINA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 100. REST OF LAMEA URINALYSIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 101. REST OF LAMEA URINALYSIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 102. REST OF LAMEA URINALYSIS, BY END USER, 2025-2033 ($MILLION)
  • TABLE 103. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 104. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 105. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 106. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 107. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. SYSMEX CORPORATION: KEY EXECUTIVES
  • TABLE 109. SYSMEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 110. SYSMEX CORPORATION: OPERATING SEGMENTS
  • TABLE 111. SYSMEX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 112. SYSMEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. SIEMENS HEALTHCARE GMBH: KEY EXECUTIVES
  • TABLE 114. SIEMENS HEALTHCARE GMBH: COMPANY SNAPSHOT
  • TABLE 115. SIEMENS HEALTHCARE GMBH: OPERATING SEGMENTS
  • TABLE 116. SIEMENS HEALTHCARE GMBH: PRODUCT PORTFOLIO
  • TABLE 117. SIEMENS HEALTHCARE GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. ACON LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 119. ACON LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 120. ACON LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 121. ACON LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 122. ACON LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. ARKRAY INC: KEY EXECUTIVES
  • TABLE 124. ARKRAY INC: COMPANY SNAPSHOT
  • TABLE 125. ARKRAY INC: OPERATING SEGMENTS
  • TABLE 126. ARKRAY INC: PRODUCT PORTFOLIO
  • TABLE 127. ARKRAY INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: KEY EXECUTIVES
  • TABLE 129. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: COMPANY SNAPSHOT
  • TABLE 130. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: OPERATING SEGMENTS
  • TABLE 131. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: PRODUCT PORTFOLIO
  • TABLE 132. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
  • TABLE 134. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 135. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
  • TABLE 136. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 137. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. QUIDEL CORPORATION: KEY EXECUTIVES
  • TABLE 139. QUIDEL CORPORATION: COMPANY SNAPSHOT
  • TABLE 140. QUIDEL CORPORATION: OPERATING SEGMENTS
  • TABLE 141. QUIDEL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 142. QUIDEL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
  • TABLE 144. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
  • TABLE 145. THERMO FISHER SCIENTIFIC INC. : OPERATING SEGMENTS
  • TABLE 146. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
  • TABLE 147. THERMO FISHER SCIENTIFIC INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
  • TABLE 149. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
  • TABLE 150. BIO-RAD LABORATORIES, INC. : OPERATING SEGMENTS
  • TABLE 151. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
  • TABLE 152. BIO-RAD LABORATORIES, INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL URINALYSIS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL URINALYSIS MARKET
  • FIGURE 3. SEGMENTATION URINALYSIS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN URINALYSIS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALURINALYSIS MARKET
  • FIGURE 11. URINALYSIS MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. URINALYSIS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 15. URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. URINALYSIS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. URINALYSIS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 18. URINALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. URINALYSIS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. URINALYSIS MARKET FOR HOME CARE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 25. COMPETITIVE DASHBOARD
  • FIGURE 26. COMPETITIVE HEATMAP: URINALYSIS MARKET
  • FIGURE 27. TOP PLAYER POSITIONING, 2024
  • FIGURE 28. ABBOTT LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. SYSMEX CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. SYSMEX CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. SYSMEX CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. SIEMENS HEALTHCARE GMBH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. SIEMENS HEALTHCARE GMBH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. SIEMENS HEALTHCARE GMBH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. ACON LABORATORIES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. ACON LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. ACON LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. ARKRAY INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. ARKRAY INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. ARKRAY INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. QUIDEL CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. QUIDEL CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. QUIDEL CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. THERMO FISHER SCIENTIFIC INC. : NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. BIO-RAD LABORATORIES, INC. : NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. BIO-RAD LABORATORIES, INC. : REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. BIO-RAD LABORATORIES, INC. : REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Urinalysis Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved